glucagon suppression, lowering hepatic glucose output Central Nervous System: Decreases food intake by targeting homeostatic and hedonic appetite pathways (hindbrain/hypothalamus), reducing hunger and cravings, and enhancing satiety Gastrointestinal Tract: Delays gastric emptying, contributing to satiety (transient effect at higher doses) Adiposity/Energy Intake : Weight loss is primarily driven by sustained reduction in caloric intake, not increased energy expenditure Biological Activity Potent GLP-1 receptor agonist Enhances insulin secretion (glucose-dependent) Suppresses glucagon secretion Reduces appetite and caloric intake Produces significant, sustained body weight loss Improves cardiometabolic risk factors (glycemia, blood pressure, lipids) Storage Refrigerate once reconstituted
If you are concerned about cardiovascular effects, it is worth understanding why Wegovy might not be working as expected to ensure you are not taking unnecessary risks for limited benefit
Most guidelines say to avoid or use with caution
A Comparison Of Dulaglutide vs Semaglutide Blood Sugar Control Studies have shown that semaglutide may be more effective than dulaglutide in lowering HbA1c levels, which is a marker for blood sugar control
Our doctors carefully listen to our clients, studies their case and advise them if it is good for them to take GLP-1 Program or not
